Ticker
SPROCompany Name
SPERO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | 0% | $ 132.81M | $ 0 |
3/31/2025 | 0% | $ 38.58M | $ 0 |
12/31/2024 | 0% | $ 48.07M | $ 0 |
9/30/2024 | 0% | $ 68.15M | $ 1K |
6/30/2024 | -0.31% | $ 72.43M | $ 221K |
3/31/2024 | -0.25% | $ 87.46M | $ 221K |
12/31/2023 | -0.25% | $ 89.42M | $ 221K |
9/30/2023 | -24.48% | $ 58.83M | $ 14.4M |
6/30/2023 | -26.58% | $ 76.41M | $ 20.31M |
3/31/2023 | -20.92% | $ 100.94M | $ 21.12M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for SPERO THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 70.17M ]) / Market Cap [ $ 377.63M ]
(=) Buyback Yield [ -18.58% ]
Minimum
Jun 30, 2022
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.7% |